Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study. - Université de Bretagne Occidentale Access content directly
Journal Articles JAMA Dermatology Year : 2013

Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.

Moez Jallouli
  • Function : Author
Du Le Thi Huong
  • Function : Author
Philippe Moguelet
Cecile Factor
  • Function : Author
Christian de Gennes
  • Function : Author
Catherine Chapelon
  • Function : Author
Bertrand Wechsler
  • Function : Author

Abstract

IMPORTANCE: Hydroxychloroquine-induced pigmentation is not a rare adverse effect. Our data support the hypothesis that hydroxychloroquine-induced pigmentation is secondary to ecchymosis or bruising. OBJECTIVE: To describe the clinical features and outcome of hydroxychloroquine (HCQ)-induced pigmentation in patients with systemic lupus erythematosus (SLE). DESIGN, SETTING, AND PARTICIPANTS: In a case-control study conducted at a French referral center for SLE and antiphospholipid syndrome, 24 patients with SLE, with a diagnosis of HCQ-induced pigmentation, were compared with 517 SLE controls treated with HCQ. MAIN OUTCOMES AND MEASURES: The primary outcome was the clinical features of HCQ-induced pigmentation. Skin biopsies were performed on 5 patients, both in healthy skin and in the pigmented lesions. The statistical associations of HCQ-induced pigmentation with several variables were calculated using univariate and multivariate analyses. RESULTS: Among the 24 patients, skin pigmentation appeared after a median HCQ treatment duration of 6.1 years (range, 3 months-22 years). Twenty-two patients (92%) reported that the appearance of pigmented lesions was preceded by the occurrence of ecchymotic areas, which gave way to a localized blue-gray or brown pigmentation that persisted. Twenty-three patients (96%) had at least 1 condition predisposing them to easy bruising. Results from skin biopsies performed on 5 patients showed that the median concentration of iron was significantly higher in biopsy specimens of pigmented lesions compared with normal skin (4115 vs 413 nmol/g; P < .001). Using multivariate logistic regression, we found that HCQ-induced pigmentation was independently associated with previous treatment with oral anticoagulants and/or antiplatelet agents and with higher blood HCQ concentration. CONCLUSIONS AND RELEVANCE: Hydroxychloroquine-induced pigmentation is not a rare adverse effect of HCQ. Our data support the hypothesis that HCQ-induced pigmentation is secondary to ecchymosis or bruising.
No file

Dates and versions

hal-00934853 , version 1 (22-01-2014)

Identifiers

Cite

Moez Jallouli, Camille Francès, Jean-Charles Piette, Du Le Thi Huong, Philippe Moguelet, et al.. Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus: a case-control study.. JAMA Dermatology, 2013, 149 (8), pp.935-40. ⟨10.1001/jamadermatol.2013.709⟩. ⟨hal-00934853⟩
139 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More